Treating GNAO1 mutation-related severe movement disorders with oxcarbazepine: a case report

BACKGROUND: GNAO1 variants have been found to be associated with epileptic encephalopathies, developmental delays (DDs), and movement disorders (MDs). Therapies for patients with GNAO1 variants vary. However, treatments for GNAO1-related diseases are still in their infancy. Previous reports suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Weihao, Huang, Danping, Yang, Fan, Yang, Zuozhen, Liu, Min, Zhu, Qiujiao, Huang, Jing, Zhou, Rui, Chen, Xuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561508/
https://www.ncbi.nlm.nih.gov/pubmed/36247896
http://dx.doi.org/10.21037/tp-22-297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561508/
https://www.ncbi.nlm.nih.gov/pubmed/36247896
http://dx.doi.org/10.21037/tp-22-297

Ejemplares similares